Vaxcyte boosts severance multipliers for CEO Pickering and three other execs effective Dec 31, 2025

Vaxcyte, Inc.

CEO Pickering: base salary severance multiplier for Qualifying Termination increases to 1.5x (from 1.0x); CIC termination to 2.0x (from 1.5x).
CFO Guggenhime, COO Wassil, CTOO Dhaliwal: non-CIC multiplier rises to 1.0x (from 0.75x/0.5x); CIC to 1.5x (from 1.0x/0.75x).
COBRA severance multipliers increased proportionally across all four executives.
Changes effective Dec 31, 2025, approved by Compensation Committee to align with peer group levels.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.